Clark Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Clark Wealth Partners's VRTX Position: Q3 2026 in Review
Clark Wealth Partners increased its Vertex Pharmaceuticals (VRTX) stake by 475% in Q3 2026, buying an estimated $9.7K and bringing the position to 23 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #237.
Clark Wealth Partners first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Clark Wealth Partners held 23 shares of Vertex Pharmaceuticals worth $12K as of Q3 2026.
- Clark Wealth Partners bought 19 Vertex Pharmaceuticals shares in Q3 2026, an estimated $9.7K.
- Vertex Pharmaceuticals made up 0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #237 holding.
- Clark Wealth Partners first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.